Furthermore, growing PD-1+ Treg cells can take up IL-2 and remove IL-2 from tumor-reactive effector T cells, leading to insufficient IL-2 required for effector T cell activation, further reducing effector T cell functions [68]. Here, IL2 is linked to neoplasm.